{"id":"https://openalex.org/W4311948718","doi":"https://doi.org/10.3389/fphar.2022.1072202","title":"Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters","display_name":"Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters","publication_year":2022,"publication_date":"2022-12-19","ids":{"openalex":"https://openalex.org/W4311948718","doi":"https://doi.org/10.3389/fphar.2022.1072202","pmid":"https://pubmed.ncbi.nlm.nih.gov/36605401","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9807602"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2022.1072202","doi":"https://doi.org/10.3389/fphar.2022.1072202","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2022.1072202","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fphar.2022.1072202","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064479176","display_name":"Rana Abdelnabi","orcid":"https://orcid.org/0000-0001-9771-7312","observed_orcids":["https://orcid.org/0000-0001-9771-7312"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Rana Abdelnabi","raw_affiliation_strings":["KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000 Leuven, Belgium","The VirusBank Platform, Gaston Geenslaan, B-3000 Leuven, Belgium","KU Leuven Department of Microbiology, Immunology, and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium","The VirusBank Platform, Leuven, Belgium"],"raw_orcid":"https://orcid.org/0000-0001-9771-7312","affiliations":[{"raw_affiliation_string":"KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000 Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]},{"raw_affiliation_string":"The VirusBank Platform, Gaston Geenslaan, B-3000 Leuven, Belgium","institution_ids":[]},{"raw_affiliation_string":"KU Leuven Department of Microbiology, Immunology, and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]},{"raw_affiliation_string":"The VirusBank Platform, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008139614","display_name":"Piet Maes","orcid":"https://orcid.org/0000-0002-4571-5232","observed_orcids":["https://orcid.org/0000-0002-4571-5232"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Piet Maes","raw_affiliation_strings":["Laboratory of Clinical and Epidemiological Virology, Rega Institute, KU Leuven, Department of Microbiology, Immunology and Transplantation, 3000, Leuven, Belgium","Zoonotic Infectious Diseases Unit, Leuven, Belgium","Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute, KU Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Clinical and Epidemiological Virology, Rega Institute, KU Leuven, Department of Microbiology, Immunology and Transplantation, 3000, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Zoonotic Infectious Diseases Unit, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute, KU Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030947556","display_name":"Steven De Jonghe","orcid":"https://orcid.org/0000-0002-3872-6558","observed_orcids":["https://orcid.org/0000-0002-3872-6558"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Steven de Jonghe","raw_affiliation_strings":["KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000 Leuven, Belgium","KU Leuven Department of Microbiology, Immunology, and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000 Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]},{"raw_affiliation_string":"KU Leuven Department of Microbiology, Immunology, and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038120191","display_name":"Birgit Weynand","orcid":"https://orcid.org/0000-0003-4246-6303","observed_orcids":["https://orcid.org/0000-0003-4246-6303"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Birgit Weynand","raw_affiliation_strings":["KU Leuven Department of Imaging and Pathology, Translational Cell and Tissue Research, B-3000 Leuven, Belgium; Division of Translational Cell and Tissue Research","Division of Translational Cell and Tissue Research, KU Leuven Department of Imaging and Pathology, Translational Cell and Tissue Research, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KU Leuven Department of Imaging and Pathology, Translational Cell and Tissue Research, B-3000 Leuven, Belgium; Division of Translational Cell and Tissue Research","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Division of Translational Cell and Tissue Research, KU Leuven Department of Imaging and Pathology, Translational Cell and Tissue Research, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089010495","display_name":"Johan H. Neyts","orcid":"https://orcid.org/0000-0002-0033-7514","observed_orcids":["https://orcid.org/0000-0002-0033-7514"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I2800687165","display_name":"Global Virus Network","ror":"https://ror.org/05jahqa08","country_code":"US","type":"other","lineage":["https://openalex.org/I2800687165"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE","US"],"is_corresponding":true,"raw_author_name":"Johan Neyts","raw_affiliation_strings":["Global Virus Network, GVN","KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000 Leuven, Belgium","The VirusBank Platform, Gaston Geenslaan, B-3000 Leuven, Belgium","Global Virus Network, GVN, Baltimore, MD, United States","KU Leuven Department of Microbiology, Immunology, and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium","The VirusBank Platform, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Virus Network, GVN","institution_ids":["https://openalex.org/I2800687165"]},{"raw_affiliation_string":"KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000 Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]},{"raw_affiliation_string":"The VirusBank Platform, Gaston Geenslaan, B-3000 Leuven, Belgium","institution_ids":[]},{"raw_affiliation_string":"Global Virus Network, GVN, Baltimore, MD, United States","institution_ids":["https://openalex.org/I2800687165"]},{"raw_affiliation_string":"KU Leuven Department of Microbiology, Immunology, and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]},{"raw_affiliation_string":"The VirusBank Platform, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5089010495"],"corresponding_institution_ids":["https://openalex.org/I24156275","https://openalex.org/I2800687165","https://openalex.org/I99464096"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":3028,"currency":"EUR","value_usd":3265},"fwci":2.0778,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.89090398,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"13","issue":null,"first_page":"1072202","last_page":"1072202"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.04450000077486038,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/remdesivir","display_name":"remdesivir","score":0.8889999985694885},{"id":"https://openalex.org/keywords/gs-441524","display_name":"GS-441524","score":0.9900000095367432},{"id":"https://openalex.org/keywords/molnupiravir","display_name":"molnupiravir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9259999990463257},{"id":"https://openalex.org/keywords/covid-19-antiviral-therapy","display_name":"COVID-19 antiviral therapy","score":0.8550000190734863},{"id":"https://openalex.org/keywords/combination-antiviral-therapy","display_name":"combination antiviral therapy","score":0.8830000162124634},{"id":"https://openalex.org/keywords/synergistic-antiviral-effect","display_name":"antiviral synergy","score":0.7739999890327454},{"id":"https://openalex.org/keywords/lethal-mutagenesis","display_name":"lethal mutagenesis","score":0.8460000157356262},{"id":"https://openalex.org/keywords/nucleoside-analogs","display_name":"nucleoside analogues","score":0.6790000200271606},{"id":"https://openalex.org/keywords/syrian-hamster-model","display_name":"Syrian hamster model","score":0.8080000281333923},{"id":"https://openalex.org/keywords/viral-load-reduction","display_name":"viral load reduction","score":0.8650000095367432},{"id":"https://openalex.org/keywords/b-1-351-variant","display_name":"B.1.351 variant","score":0.8029999732971191}],"concepts":[{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.826934278011322},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.6356022357940674},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6333272457122803},{"id":"https://openalex.org/C2779772310","wikidata":"https://www.wikidata.org/wiki/Q16934561","display_name":"Favipiravir","level":5,"score":0.6169117093086243},{"id":"https://openalex.org/C106358424","wikidata":"https://www.wikidata.org/wiki/Q1662346","display_name":"Infectivity","level":3,"score":0.5996023416519165},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5813128352165222},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5509114861488342},{"id":"https://openalex.org/C2779756493","wikidata":"https://www.wikidata.org/wiki/Q846227","display_name":"Antiviral drug","level":3,"score":0.4870660603046417},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4705389142036438},{"id":"https://openalex.org/C2776824251","wikidata":"https://www.wikidata.org/wiki/Q423445","display_name":"Cidofovir","level":3,"score":0.43132734298706055},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.4287763833999634},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.4263271987438202},{"id":"https://openalex.org/C2778575167","wikidata":"https://www.wikidata.org/wiki/Q6573","display_name":"Hamster","level":2,"score":0.4180343747138977},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3339110016822815},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.239926278591156},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14556005597114563},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.11650773882865906},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.11536762118339539},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08231902122497559},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.3389/fphar.2022.1072202","doi":"https://doi.org/10.3389/fphar.2022.1072202","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2022.1072202","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"doi:10.1101/2022.10.13.512054","doi":"https://doi.org/10.1101/2022.10.13.512054","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2022.10.13.512054","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2022/10/13/2022.10.13.512054.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:9807602","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9807602","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:36605401","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36605401","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:20.500.12942/710719","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/20.500.12942/710719","pdf_url":"https://lirias.kuleuven.be/retrieve/3e8a657e-4e5d-4e59-be4c-f8d07ee26d1b","source":{"id":"https://openalex.org/S4306401954","display_name":"Lirias (KU Leuven)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers In Pharmacology, vol. 13, Art.No. ARTN 1072202","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:32a022de172346eca43b6d44f9b82a39","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/32a022de172346eca43b6d44f9b82a39","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 13 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2022.1072202","doi":"https://doi.org/10.3389/fphar.2022.1072202","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2022.1072202","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1679872580","display_name":"Katholieke Universiteit Leuven - to screen Reframe library against Covid-19","funder_award_id":"INV-006366","funder_id":"https://openalex.org/F4320306137","funder_display_name":"Bill and Melinda Gates Foundation"},{"id":"https://openalex.org/G2594633648","display_name":null,"funder_award_id":"101003627","funder_id":"https://openalex.org/F4320306137","funder_display_name":"Bill and Melinda Gates Foundation"},{"id":"https://openalex.org/G2605422190","display_name":null,"funder_award_id":"101005077","funder_id":"https://openalex.org/F4320314178","funder_display_name":"European Federation of Pharmaceutical Industries and Associations"},{"id":"https://openalex.org/G27526698","display_name":null,"funder_award_id":"101005077","funder_id":"https://openalex.org/F4320306137","funder_display_name":"Bill and Melinda Gates Foundation"},{"id":"https://openalex.org/G4103011049","display_name":"Corona Accelerated R&D in Europe","funder_award_id":"101005077","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G434337789","display_name":null,"funder_award_id":"HORIZON2020","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G5409925101","display_name":null,"funder_award_id":"101005077","funder_id":"https://openalex.org/F4320326631","funder_display_name":"Innovative Medicines Initiative"},{"id":"https://openalex.org/G5977900945","display_name":null,"funder_award_id":"G0G4820N","funder_id":"https://openalex.org/F4320322308","funder_display_name":"KU Leuven"},{"id":"https://openalex.org/G6122222817","display_name":null,"funder_award_id":"COVID-19","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G6305477373","display_name":null,"funder_award_id":"101005077","funder_id":"https://openalex.org/F4320310838","funder_display_name":"University of Dundee"},{"id":"https://openalex.org/G6757056068","display_name":"DEVELOPMENT AND USE OF RELEVANT HAMSTER AND MOUSE SARS-COV-2 INFECTION MODELS TO AID IN THE DESIGN OF THERAPEUTIC AND PROPHYLACTIC OPTIONS FOR COVID-19","funder_award_id":"G0G4820N","funder_id":"https://openalex.org/F4320321730","funder_display_name":"Fonds Wetenschappelijk Onderzoek"},{"id":"https://openalex.org/G7905289576","display_name":null,"funder_award_id":"G0G4820N","funder_id":"https://openalex.org/F4320306137","funder_display_name":"Bill and Melinda Gates Foundation"},{"id":"https://openalex.org/G838529247","display_name":"Swift COronavirus therapeutics REsponse","funder_award_id":"101003627","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G8471316792","display_name":null,"funder_award_id":"101003627","funder_id":"https://openalex.org/F4320310838","funder_display_name":"University of Dundee"},{"id":"https://openalex.org/G8796584861","display_name":null,"funder_award_id":"101003627","funder_id":"https://openalex.org/F4320314178","funder_display_name":"European Federation of Pharmaceutical Industries and Associations"},{"id":"https://openalex.org/G8983293788","display_name":null,"funder_award_id":"G0G4820N","funder_id":"https://openalex.org/F4320335514","funder_display_name":"Universitaire Ziekenhuizen Leuven, KU Leuven"}],"funders":[{"id":"https://openalex.org/F4320306137","display_name":"Bill and Melinda Gates Foundation","ror":"https://ror.org/0456r8d26"},{"id":"https://openalex.org/F4320310838","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36"},{"id":"https://openalex.org/F4320314178","display_name":"European Federation of Pharmaceutical Industries and Associations","ror":"https://ror.org/00g1x4v36"},{"id":"https://openalex.org/F4320315885","display_name":"Australian Government","ror":"https://ror.org/0314h5y94"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320321730","display_name":"Fonds Wetenschappelijk Onderzoek","ror":"https://ror.org/03qtxy027"},{"id":"https://openalex.org/F4320322308","display_name":"KU Leuven","ror":"https://ror.org/05f950310"},{"id":"https://openalex.org/F4320326631","display_name":"Innovative Medicines Initiative","ror":"https://ror.org/019af4n30"},{"id":"https://openalex.org/F4320335514","display_name":"Universitaire Ziekenhuizen Leuven, KU Leuven","ror":"https://ror.org/0424bsv16"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W2256756668","https://openalex.org/W2292021561","https://openalex.org/W2605336808","https://openalex.org/W2770157223","https://openalex.org/W2786899877","https://openalex.org/W2912059100","https://openalex.org/W2981723136","https://openalex.org/W3014708904","https://openalex.org/W3025511956","https://openalex.org/W3032677067","https://openalex.org/W3032915827","https://openalex.org/W3036749055","https://openalex.org/W3036811792","https://openalex.org/W3092285496","https://openalex.org/W3094659917","https://openalex.org/W3105815895","https://openalex.org/W3110209099","https://openalex.org/W3110466220","https://openalex.org/W3119203274","https://openalex.org/W3126546961","https://openalex.org/W3127380759","https://openalex.org/W3136539592","https://openalex.org/W3154750958","https://openalex.org/W3162323249","https://openalex.org/W3164640404","https://openalex.org/W3180181011","https://openalex.org/W3200454547","https://openalex.org/W3201297794","https://openalex.org/W4200206478","https://openalex.org/W4210617276","https://openalex.org/W4212844110","https://openalex.org/W4212904481","https://openalex.org/W4220854172","https://openalex.org/W4220976155","https://openalex.org/W4225291179","https://openalex.org/W4232207133","https://openalex.org/W4281700140"],"related_works":["https://openalex.org/W4402168679","https://openalex.org/W3200454547","https://openalex.org/W4210617276","https://openalex.org/W4399481757","https://openalex.org/W6901840505","https://openalex.org/W4302362695","https://openalex.org/W4402919511","https://openalex.org/W7212018333","https://openalex.org/W3198788991","https://openalex.org/W4286434216"],"abstract_inverted_index":{"Abstract":[0],"Remdesivir":[1],"was":[2,95,106,170],"the":[3,10,25,44,54,76,92,109,153,175,183,193,238],"first":[4],"drug":[5],"to":[6,40,52,152,224],"be":[7,225],"approved":[8],"for":[9,117,247],"treatment":[11,105,246],"of":[12,20,30,46,58,63,111,177,180,182,207,237],"severe":[13],"COVID-19;":[14],"followed":[15],"by":[16,143,198,211],"molnupiravir":[17,66,132,162,208],"(another":[18],"prodrug":[19],"a":[21,86,220,244],"nucleoside":[22,62],"analogue)":[23],"and":[24,38,65,113,131,145,161,190,215],"protease":[26],"inhibitor":[27],"nirmatrelvir.":[28],"Combination":[29],"antiviral":[31,56,83,205,235],"drugs":[32],"may":[33],"result":[34],"in":[35,79,97,174,192,228],"improved":[36],"potency":[37,57],"help":[39],"avoid":[41],"or":[42],"delay":[43],"development":[45],"resistant":[47],"variants.":[48],"We":[49],"set":[50],"out":[51,179],"explore":[53],"combined":[55,93,204],"GS-441524":[59,126,157],"(the":[60],"parent":[61],"remdesivir)":[64],"against":[67],"SARS-CoV-2.":[68],"In":[69],"SARS-CoV-2":[70,102,230],"(BA.5)":[71],"infected":[72,100],"A549-Dual\u2122":[73],"hACE2-TMPRSS2":[74],"cells,":[75],"combination":[77,239],"resulted":[78],"an":[80],"overall":[81],"additive":[82],"effect":[84,94,236],"with":[85,101],"synergism":[87],"at":[88,108],"certain":[89],"concentrations.":[90],"Next,":[91],"explored":[96],"Syrian":[98],"hamsters":[99,185],"(Beta,":[103],"B.1.351);":[104],"started":[107],"time":[110],"infection":[112],"continued":[114],"twice":[115],"daily":[116],"four":[118],"consecutive":[119],"days.":[120],"At":[121],"4":[122,124],"day":[123],"post-infection,":[125],"(50":[127,158],"mg/kg,":[128,134,159,164],"oral":[129,135],"BID)":[130,136,160,165],"(150":[133,163],"as":[137,219,243],"monotherapy":[138],"reduced":[139,197],"infectious":[140,168],"viral":[141],"loads":[142],"0.5":[144],"1.6":[146],"log":[147,187,200],"10":[148,181,188,201],",":[149],"respectively,":[150],"compared":[151],"vehicle":[154],"control.":[155],"When":[156],"were":[166,196],"combined,":[167],"virus":[169],"no":[171],"longer":[172],"detectable":[173],"lungs":[176],"7":[178],"treated":[184],"(4.0":[186],"reduction)":[189],"titers":[191],"other":[194],"animals":[195],"~2":[199],".":[202],"The":[203,232],"activity":[206],"which":[209,217],"acts":[210,218],"inducing":[212],"lethal":[213],"mutagenesis":[214],"GS-441524,":[216],"chain":[221],"termination":[222],"appears":[223],"highly":[226],"effective":[227],"reducing":[229],"replication/infectivity.":[231],"unexpected":[233],"potent":[234],"warrants":[240],"further":[241],"exploration":[242],"potential":[245],"COVID-19.":[248]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2023-01-03T00:00:00"}